Clinical Trial Update: Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study

View source ↗

Summary

This clinical trial update describes the CALIBER study assessing morbidity and mortality in patients with hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: University College, London | Conditions: Hypertrophic Cardiomyopathy | Status: UNKNOWN